Oncomarkers no nā wāhine

ʻO ka papa o nā mea hōʻailona hoʻolaha i loko o nā mea heʻoi aku iʻoi aku ma mua o 20 mau, aʻo kekahi o ia mau mea he loiloi wale nō i nā maʻi o ke kino male, e like me ka maʻi maʻi prostate. No laila, ua hāʻawiʻia nā hiʻohiʻona kūikawā no nā wāhine i loko o ka hale wehewehe, e'āpono iā mākou e hōʻoia i nāʻano maʻamauʻole wale nō, akā, i nāʻano kiko'ī o nā neoplasms malia.

He aha nā mea heleʻole no nā wāhine?

ʻO ka mea maʻamau, ua hoʻonohonohoʻia kekahi pūhui hoʻohui pūnaewele i hoʻonohonohoʻia no kaʻike mua o ka maʻi wahine.

ʻO nā kumuhana ma luna o nā wāhine:

1. SCC. Hanaʻia no kaʻike mua o ka carcinoma o ka pūpū , pepeiao a nasopharynx. Ma keʻano paʻakikī, ua hōʻoia ka hōʻoia i ka carcinoma kahe liʻiliʻi a me ka carcinoma pūmaʻi pūpū.
2. CA 125. Loaʻa i ka maʻiʻauana o ka wahine.
3. CA 15-3. Hōʻike i ka maʻi kanesa a me ka hana kuʻuna. I ka hopena o ka holomua o ka maʻilekolekoʻole, endometrial a me nā pūpū o ke kino, nā mumū,ʻo ka mea hōʻike hoʻi e hoʻonui.
4. ISA. ʻO ia no ka nānāʻana a me ka hōʻoia o ka maʻi kanesa o ka maʻi.
5. CA 72-4. Nānāʻia no ka lāʻauʻawaʻawa, ka huhu a me ka maʻi'epū.
6. NCE. Ke nānāʻia nei i nā neuroblastomas, ka maʻi liʻiliʻi liʻiliʻi liʻiliʻi, leukemia .
7. REA. Ua kauohaʻia no ka hōʻoia muaʻana o nā maʻi koko o ka pāʻono, ka'ōpū nui. Hāʻawi i ka hōʻoia o ka maʻi hanu o nā mumū,ʻo ka mammary glands, a me nāʻano o nā mea ola'ē aʻe.
8. CA 19-9. Loaʻaʻia ia i ka maʻi kanesa o ka maʻi pancreatic. Hoʻomaopopo ka hoʻokolohua i nā neoplasms ma ka'ōpū, ka naʻau, nā mumū, nā lehua a me nā lewa.
9. CYFRA 21-1. Hoʻohanaʻia no ka hōʻoia muaʻana o ka maʻiʻeha o ka maʻi puʻupuʻu liʻiliʻi, ka carcinoma pūpū.
10. HCG. Hoʻohanaʻiaʻo ia eʻike i nāʻano maʻi he nui. Eia kekahi, hCG i loko o ke koko i ke kanesa o nā ovaries, kōpū, ka opu, nā puʻupaʻa, ka'ōpū nui a me kaʻuʻuku, ate, me ke kāpili a me ka choriocarcinoma.
11. AFP. Pono pono ka wehewehe no ka hōʻoia o ka carcinoma hepatocellular, germinoma. Nānāʻia no ka pilikia o ka hoʻouluʻana o ka hānai o ka'ōpiopio, hiki iā ia keʻike i ka Down syndrome, ka hana kūponoʻole o ka pāpana abdominal, neural tube.

ʻO keʻano o nā māmā o nā mea i kākauʻia e pono ai e hāʻawiʻia i nā wāhine ke hoʻopakele wale i nā kauka hele. ʻAʻole pono ka nānāʻana i ke koko no ka hikiʻana mai o nā pūlālā pūpili'ē aʻe, no ka mea he mea nui eʻike i nāʻano o nā glycoproteins e hiki ai ke hoʻoholo i ka hōʻailona.

Ke kūlana maʻamau o nā mea heleʻole no nā wāhine

ʻO nā hopena o ka hōʻoiaʻana o ka pilina o ka maʻi hōʻailonaʻaʻole i ka hōʻoia a hōʻole i nā manaʻo kānalua o ka maʻi kanesa, akā, no ka hahaiʻana i ka maikaʻi o ka lawelaweʻana i nā lāʻau lapaʻau maʻamau.

Ke kūlana maʻamau o nā mea alaʻole i ke koko o nā wāhine:

• SCC - 0-2.5 ng / ml;
• CA 125 - i 30 IU / ml;
• CA 15-3 - ma mua o 22 IU / ml;
• ʻAʻoleʻo MSA - ma mua o 11 IU / ml;
• CA 72-4 - 0 i 4 IU / ml;
• NCE - i ka 15 ng / ml;
• REA - 0-5 ng / ml;
• CA 19-9 -ʻaʻole iʻoi aku i ka 30 IU / ml;
• CYFRA 21-1 - palena: 2.3 ng / ml;
• HCG - i hiki i 5 IU / ml;
• AFP - 0-5 IU / ml.

Pehea e lawe ai i nā konohiki no nā wāhine?

ʻO nā rula no ka hāʻawiʻana i ke koko no ka loiloiʻana he mea pono ia e hele mai no ka hōʻiliʻiliʻana i ka'ōpū o ka'ōpū,ʻoi aku i ke kakahiaka. C ʻo ka manawa o ka meaʻai mua i hala e 8 mau hola.

ʻO kahi o ka hopena o nā hulu'ōpona e pono e hāʻawiʻia i kahi wahine no ka paleʻana?

Ke hāʻawiʻia nei keʻano kūpono o kaʻano o ka noi i noiʻia,ʻaʻole i kauʻia no nā kumu hana prophylactic. ʻO ka meaʻoiaʻiʻo, aia ma nā mea ola nā māmā i nā waiola olaola o nā wāhine pono loa. No laila, mai hoʻomohala wale i ka pūnaewele hopohopo e hoʻohaʻahaʻa a nānā i ka hopena o ka uluʻana i ka maʻi kanesa. Hoʻonohonohoʻiaʻo Oncoscreening e hōʻoia i kahi hōʻailonaʻike muaʻia, a me ka nānāʻana i ka pono o chemotherapy, radiation.